Financials
Income statement
| Fiscal date | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total reported revenue | 144.6B | 124.9B | 117.2B | 115.4B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | 707.2M | 763.1M | 453.4M |
| Other operating expenses | 20.6B | 16.0B | 12.8B | 8.9B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 36.2B | 29.4B | 28.9B | 1.3B |
| Tax provision | 8.8B | 7.1B | 7.0B | 28.3M |
| Net income | 27.5B | 22.3B | 21.9B | 1.3B |
| Basic EPS | 17.0 | 13.8 | 13.6 | 0.8 |
| Diluted EPS | 17.0 | 13.8 | 13.6 | 0.8 |
| Basic average shares | 1.6B | 1.6B | 1.6B | 1.6B |
| Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 36.2B | 29.4B | 28.9B | 1.3B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |